(855) leva - 594 info@renoviainc.com
  • Linkedin
  • Linkedin
  • leva Login
Renovia Inc
  • leva ® Digital Therapeutic
    • What is Pelvic Health?
    • What is leva®?
    • How to get leva®?
    • Videos
  • For Patients
    • leva® FAQ
    • leva® Digital Therapeutic Instructions for Use
    • First-Generation leva® Instructions for Use
    • E-Sign Patient Authorization First-Generation leva®
  • Clinical Evidence
    • Renovia Clinical Trial
    • Pilot Study Publication
  • About
    • Leadership
    • Advisors
  • News
  • Careers
  • Contact
Select Page

LES005.3.09B Renovia Agreement 30Oct18 FINAL

by Renovia | Nov 26, 2018

LES005.3.09B-Renovia-Agreement-30Oct18-FINAL

Recent Press Releases

  • Renovia names new president and CEO; Completes enrollment for randomized controlled trial.
  • Renovia presents at Piper Sandler Healthcare Conference
  • Renovia Announces FDA 510(k) Clearance of Next-Generation leva® Pelvic Digital Therapeutic
  • Renovia Study Results Published in Neurology and Urodynamics Show Positive Results for leva® Pelvic Digital Therapeutic in Treating Female Urinary Incontinence
  • Renovia Inc. Nominated for MedTech Company of the Year at the New England Venture Capital Association’s 2019 NEVYs Awards
  • Renovia Names Jim O’Connor as General Counsel & Senior Vice President, Strategic Development

Recent News

  • Renovia names new president and CEO; Completes enrollment for randomized controlled trial.
  • Renovia presents at Piper Sandler Healthcare Conference
  • Renovia Announces FDA 510(k) Clearance of Next-Generation leva® Pelvic Digital Therapeutic

Learn More

Renovia Inc.

263 Summer Street
Boston, MA 02210 

Corporate: (866) 735-8424
Renovia Women’s Center:
(855) leva – 594 or
(855) 538-2594
Fax: (888) 503-7788
info@renoviainc.com

  • Linkedin
© 2019 Renovia Inc. All rights reserved.

Privacy Policy | Terms and Conditions